Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNS60 for post-operative pain in hip labral repair
NCT02005523Phase 2Withdrawn
- Sponsor
- Revalesio Corporation
- Primary completion
- Oct 2014
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of RNS60 in postoperative pain, sponsored by Revalesio Corporation. Status: withdrawn.
02
Drugs
RNS60
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02005523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005523.